Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006

Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States

Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673

Influenza-Associated Hospitalizations in the United States

Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

Fiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 1,964

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789

The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature

Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-7-199510010-00008 · Cited by 1,100

The Efficacy of Influenza Vaccination in Elderly Individuals

Govaert, T. M. E. (1994) · JAMA · doi:10.1001/jama.1994.03520210045030 · Cited by 883

Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population

Simonsen, L., Reichert, T. A., Viboud, C. G., Blackwelder, W. C., Taylor, R. J., & Miller, M. A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.265 · Cited by 541

Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older

Falsey, A. R., Treanor, J. J., Tornieporth, N., Capellan, J., & Gorse, G. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599790 · Cited by 388

Influenza Activity — United States, 2015–16 Season and Composition of the 2016–17 Influenza Vaccine

Davlin, S. L., Blanton, L., Kniss, K. L., Mustaquim, D., Smith, S., Kramer, N. A., Cohen, J., Cummings, C. N., Garg, S., Flannery, B. L., et al. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6522a3 · Cited by 328

The Prevention of Infections in Older Adults: Vaccination

Coll, P. P., Costello, V. W., Kuchel, G. A., Bartley, J. M., & McElhaney, J. E. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16205 · Cited by 22

Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older

Pillsbury, A., Fathima, P., Quinn, H., Cashman, P. M., Blyth, C. C., Leeb, A., & Macartney, K. K. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.4079 · Cited by 22

Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications

McKinnon, J. E., & Maksimowicz‐McKinnon, K. (2015) · Translational research · doi:10.1016/j.trsl.2015.08.008 · Cited by 23

High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults

Johansen, N. D., Modin, D., Loiacono, M. M., Harris, R. C., Dufournet, M., Larsen, C. S., Larsen, L., Wiese, L., Dalager‐Pedersen, M., Claggett, B. L., et al. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.3460 · Cited by 22

Antibody and Cell-Mediated Immune Responses Are Correlates of Protection against Influenza Infection in Vaccinated Older Adults

Verschoor, C. P., Andrew, M. K., Loeb, M. B., Pawelec, G., Haynes, L., Kuchel, G. A., & McElhaney, J. E. (2021) · Vaccines · doi:10.3390/vaccines9010025 · Cited by 21

Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trial

Johansen, N. D., Modin, D., Skaarup, K. G., Nealon, J., Samson, S., Dufournet, M., Loiacono, M. M., Harris, R. C., Larsen, C. S., Jensen, A. M. R., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.01.017 · Cited by 21

Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial

Carter, C., Houser, K. V., Yamshchikov, G. V., Bellamy, A. R., May, J. M., Enama, M. E., Sarwar, U. N., Larkin, B. D., Bailer, R. T., Koup, R. A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222178 · Cited by 21

Recommendations for influenza and Streptococcus pneumoniae vaccination in elderly people in China

Chen, Q., Wang, L., Xie, M., Li, X., & Recommendations for Influenza, S. P. V. I. E. P. I. C. W. G. (2020) · Aging Medicine · doi:10.1002/agm2.12102 · Cited by 21

Better, Faster, Stronger: mRNA Vaccines Show Promise for Influenza Vaccination in Older Adults

Bartley, J. M., Cadar, A. N., & Martin, D. E. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1909617 · Cited by 21

Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial

Sanchez, L., Matsuoka, O., Inoue, S., Inoue, T., Meng, Y., Nakama, T., Kato, K., Pandey, A., & Chang, L.-J. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1677437 · Cited by 21

Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias

Branagan, A. R., Duffy, E. J., Gan, G., Li, F., Foster, C., Verma, R., Zhang, L., Parker, T. L., Seropian, S., COOPER, D. L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003880 · Cited by 20

Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta‐regression analysis

Panatto, D., Signori, A., Lai, P. L., Gasparini, R., & Amicizia, D. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12550 · Cited by 21

Strategies to maximize influenza vaccine impact in older adults

Whitaker, J. A., von Itzstein, M. S., & Poland, G. A. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.040 · Cited by 20

Systematic Review on the Cost-Effectiveness of Seasonal Influenza Vaccines in Older Adults

Loong, D., Pham, B., Amiri, M., Saunders, H., Mishra, S., Radhakrishnan, A., Rodrigues, M., Yeung, M. W., Muller, M. P., Straus, S. E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2022.03.011 · Cited by 20

Does influenza vaccination influence cardiovascular complications?

Udell, J. A., Farkouh, M. E., Solomon, S. D., & Vardeny, O. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1044439 · Cited by 20

Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza A viruses in mice

Moriyama, M., Rodrigues, G. R., Wang, J., Jayewickreme, R., Hudak, A., Dong, H., Homer, R., Ma, S., & Iwasaki, A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2422171122 · Cited by 21

Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design

Zimmerman, R. K., Nowalk, M. P., Dauer, K., Clarke, L. G., Raviotta, J. M., & Balasubramani, G. K. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.06.056 · Cited by 19

Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS

Nehar-Belaid, D., Sokolowski, M. J., Ravichandran, S., Banchereau, J., Chaussabel, D., & Ucar, D. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101842 · Cited by 19

Old drug, new tricks: the utility of metformin in infection and vaccination responses to influenza and SARS-CoV-2 in older adults

Martin, D. E., Cadar, A. N., & Bartley, J. M. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1272336 · Cited by 21

Influenza vaccine effectiveness among healthcare workers in comparison to hospitalized patients: A 2004-2009 case-test, negative-control, prospective study

Vanhems, P., Baghdadi, Y., Roche, S., Bénet, T., Régis, C., Lina, B., Robert, O., Voirin, N., Écochard, R., & Amour, S. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1079677 · Cited by 19

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors

Becker, D. L., Chit, A., DiazGranados, C. A., Maschio, M., Yau, E., & Drummond, M. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1215395 · Cited by 19

Alternative-Dose versus Standard-Dose Trivalent Influenza Vaccines for Immunocompromised Patients: A Meta-Analysis of Randomised Control Trials

Lai, J.-J., Lin, C. S., Ho, C., Chen, P., & Lee, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050590 · Cited by 19

Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness

Young, B. E., Mak, T. M., Ang, L. W., Sadarangani, S. P., Ho, H. J. A., Wilder‐Smith, A., Barkham, T., & Chen, M. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820002952 · Cited by 19

Better Response to Influenza Virus Vaccination in Physically Trained Older Adults Is Associated With Reductions of Cytomegalovirus-Specific Immunoglobulins as Well as Improvements in the Inflammatory and CD8+ T-Cell Profiles

Felismino, E. S., Santos, J. M. B., Rossi, M. N., Santos, C. A. F., Durigon, E. L., Oliveira, D. B. L., Thomazelli, L. M., Monteiro, F. R., Sperandio, A., Apostólico, J. D. S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.713763 · Cited by 19

Erratum to: Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years

Lu, Y., Chillarige, Y., Izurieta, H. S., Wei, Y., Xu, W., Lu, M., Sung, H.-M., Lindaas, A., Wernecke, M., MaCurdy, T. E., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz463 · Cited by 19

Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States

La, E. M., Graham, J., Singer, D., Molnar, D., Poston, S. A., Curran, D., Pickett, J., & Verelst, F. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2432745 · Cited by 18

Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination

Tong, X., Deng, Y., Cizmeci, D., Fontana, L., Carlock, M. A., Hanley, H. B., McNamara, R. P., Lingwood, D., Ross, T. M., & Alter, G. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200956 · Cited by 18

Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition

Choi, W. S., Song, J. Y., Kwon, K. T., Lee, H.-J., Choo, E. J., Baek, J. H., Chin, B., Kim, W. J., Lee, M. S., Park, W. B., et al. (2024) · Infection and Chemotherapy · doi:10.3947/ic.2023.0072 · Cited by 19

The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021–2022 influenza season

Bricout, H., LEVANT, M.-C., Assi, N., Crépey, P., Descamps, A., Mari, K., Gaillat, J., Gavazzi, G., Grenier, B., Launay, O., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.08.012 · Cited by 18

Control of type 1 error in a hybrid complete two‐period vaccine efficacy trial

Dunning, A. J., & Reeves, J. (2014) · Pharmaceutical Statistics · doi:10.1002/pst.1649 · Cited by 18

Cost Benefit of High-Dose vs Standard-Dose Influenza Vaccine in a Long-Term Care Population During an A/H1N1-Predominant Influenza Season

Shireman, T. I., Ogarek, J. A., Gozalo, P. L., Zhang, T., Mor, V., Davidson, H. E., Han, L., Taljaard, M., & Gravenstein, S. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.12.003 · Cited by 18

High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial

Stapleton, J. T., Wagner, N., Tuetken, R. S., Bellamy, A. R., Hill, H., Kim, S., & Winokur, P. L. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.04.002 · Cited by 18

Fractures and Fall Injuries after Hospitalization for Seasonal Influenza - A National Retrospective Cohort Study

Axelsson, K. F., Litsne, H., & Lorentzon, M. (2020) · Osteoporosis International · doi:10.1007/s00198-021-06068-1 · Cited by 18

Clinical efficacy and safety of high dose trivalent influenza vaccine in adults and immunosuppressed populations – A systematic review and meta-analysis

Weissman, Y. L., Cooper, L., Sternbach, N., Ashkenazi‐Hoffnung, L., & Yahav, D. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.08.028 · Cited by 18

Vaccines against major ICU pathogens: where do we stand?

Pletz, M. W., Uebele, J., Götz, K., Hagel, S., & Bekeredjian‐Ding, I. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000338 · Cited by 18

Comparing Influenza Vaccine Types: The Path Toward Improved Influenza Vaccine Strategies

Flannery, B. L., & Fry, A. M. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy717 · Cited by 18

Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Geriatrics and Gerontology, and the Study Group of Geriatrics of the Portuguese Society of Internal Medicine

Froes, F., Timóteo, A. L. P. P., Almeida, B., Raposo, J. F., de Oliveira, J. E. D., Carrageta, M., Duque, S., & Morais, A. (2023) · Pulmonology · doi:10.1016/j.pulmoe.2023.11.003 · Cited by 17

Enhanced influenza vaccination for older adults in Europe: a review of the current situation and expert recommendations for the future

Gavazzi, G., Fougère, B., Hanon, O., Leroux‐Roels, I., Brochot, É., Blanchard, É., Russell, C. A., Paccalin, M., & Schwarz, T. F. (2025) · Expert Review of Vaccines · doi:10.1080/14760584.2025.2499728 · Cited by 17

Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity

Ford, B. N., & Savitz, J. B. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00288-7 · Cited by 18

The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany

Kohli, M. A., Maschio, M., Cartier, S., Mould-Quevedo, J. F., & Fricke, F.-U. (2022) · Vaccines · doi:10.3390/vaccines10091386 · Cited by 17

Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden

Jacob, J., Biering‐Sørensen, T., Ehlers, L. H., Edwards, C. H., Mohn, K. G.-I., Nilsson, A. M., Hjelmgren, J., Ma, W., Sharma, Y., Ciglia, E., et al. (2023) · Vaccines · doi:10.3390/vaccines11040753 · Cited by 17

Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination

Linterman, M. A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101801 · Cited by 17

A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly

Mullikin, M., Tan, L., Jansen, J. P., Ranst, M. A. V., Farkas, N., & Petri, E. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0076-8 · Cited by 17

Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants

Chong, Y., & Ikematsu, H. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.084 · Cited by 17

Comparison of Side Effects of the 2015–2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults ≥65 Years

Kaka, A. S., FILICE, G. A., Myllenbeck, S., & Nichol, K. L. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx001 · Cited by 17

Mathematical models of transmission dynamics and vaccine strategies in Hong Kong during the 2017–2018 winter influenza season

Ho, S. H., He, D., & Eftimie, R. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.05.013 · Cited by 17

Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis

Butler, A. M., Layton, J. B., Dharnidharka, V. R., Sahrmann, J. M., Seamans, M. J., Weber, D. J., & McGrath, L. J. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.05.018 · Cited by 17

Quantifying the annual incidence and underestimation of seasonal influenza: A modelling approach

McCarthy, Z., Athar, S., Alavinejad, M., Chow, C., Moyles, I. R., Nah, K., Kong, J. D., Agrawal, N., Jaber, A., Keane, L., et al. (2020) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-020-00129-4 · Cited by 17

Immune responses of meningococcal B outer membrane vesicles in middle-aged mice

de Lima, G. T., Rodrigues, T. S., Portilho, A. I., Correa, V. A., Gaspar, E. B., & Gaspari, E. D. (2020) · Pathogens and Disease · doi:10.1093/femspd/ftaa028 · Cited by 17

The Role of Systems Vaccinology in Understanding the Immune Defects to Vaccination in Solid Organ Transplant Recipients

Scanlon, N., Saklawi, Y., & Rouphael, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582201 · Cited by 17

Vaccinations in Older Adults

Burke, M., & Rowe, T. A. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.08.006 · Cited by 17

Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022–2023 Influenza Season Among Adults ≥65 Years of Age

Ku, J. H., Rayens, E. A., Sy, L. S., Qian, L., Ackerson, B. K., Luo, Y., Tubert, J. E., Lee, G. S., Modha, P. P., Park, Y., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae375 · Cited by 16

Relationship between meteorological variations, seasonal influenza, and hip fractures in the elderly: A modelling investigation using 22-year data

Li, C., Jiang, X., Yue, Q., Wei, Y., Wang, Y., Ho, J., Lao, X. Q., & Chong, K. C. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.160764 · Cited by 16

Influenza vaccination in patients affected by diabetes

Verket, M., Jacobsen, M., Schütt, K. S., Marx, N., & Müller‐Wieland, D. (2023) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac119 · Cited by 16

Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease

Peikert, A., Claggett, B. L., Udell, J. A., Joseph, J., Hegde, S. M., Kim, K., Mao, L., Wang, T., Havighurst, T. C., Farkouh, M. E., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.0468 · Cited by 16

Immunogenicity of Enhanced Influenza Vaccines Against Mismatched Influenza Strains in Older Adults: A Review of Randomized Controlled Trials

Youhanna, J. E., Tran, V., Hyer, R. N., & Domnich, A. (2024) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13286 · Cited by 16

Trivalent and quadrivalent seasonal influenza vaccine in adults aged 60 and older: a systematic review and network meta-analysis

Veroniki, A. A., Thirugnanasampanthar, S. S., Konstantinidis, M., Dourka, J., Ghassemi, M., Neupane, D., Khan, P. A., Nincic, V., Corry, M., Robson, R. C., et al. (2024) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2023-112767 · Cited by 18

High‐Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults

PALMU, A. A. I., Pépin, S., Syrjänen, R., Mari, K., Moore, T. M., Jokinen, J., Nieminen, H. P., Kilpi, T. M., Samson, S., & Bruijn, I. D. (2024) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13270 · Cited by 16

Chronic obstructive pulmonary disease and influenza vaccination effect in preventing outpatient and inpatient influenza cases

Martínez‐Baz, I., Casado, I., Navascués, A., Portillo, M. E., Guevara, M., Ezpeleta, C., & Castilla, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-08952-0 · Cited by 16

Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)

Pott, H., Andrew, M. K., Shaffelburg, Z., Nichols, M. K., Ye, L., ElSherif, M. S., Hatchette, T. F., LeBlanc, J. J., Ambrose, A., Boivin, G., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.08.070 · Cited by 16

Prospective comparative study of characteristics associated with influenza A and B in adults

Chagvardieff, A., Persico, N., Marmillot, C., Badiaga, S., Charrel, R. N., & Roch, A. (2017) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2017.11.007 · Cited by 15

A Review and Meta-Analysis of Influenza Interactome Studies

Chua, S. C. J. H., Cui, J., Engelberg, D., & Lim, L. H. K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.869406 · Cited by 15

Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis

Quach, H. Q., & Kennedy, R. B. (2022) · Viruses · doi:10.3390/v14112438 · Cited by 15

Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations

Purcell, R. A., Theisen, R. M., Arnold, K. B., Chung, A. W., & Selva, K. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1183727 · Cited by 16

Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations

van der Pol, S., Zeevat, F., Postma, M. J., & Boersma, C. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.04.040 · Cited by 15

Relative Effectiveness of the MF59®‐Adjuvanted Influenza Vaccine Versus High‐Dose and Non‐Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019–2020 US Influenza Season

Imran, M., Puig‐Barberà, J., Ortiz, J. R., López-González, L., Dean, A., Bonafede, M., & Haag, M. D. M. (2024) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13288 · Cited by 18

Relative Effectiveness of High-Dose Versus Standard-Dose Quadrivalent Influenza Vaccine in Older Adults With Cardiovascular Disease: A Prespecified Analysis of the DANFLU-1 Randomized Clinical Trial

Christensen, J., Johansen, N. D., Modin, D., Janstrup, K. H., Nealon, J., Samson, S., Loiacono, M. M., Harris, R. C., Larsen, C. S., Jensen, A. M. R., et al. (2024) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.124.011496 · Cited by 15

Relative Efficacy, Effectiveness and Safety of Newer and/or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory‐Confirmed Influenza in Individuals Aged 18 years and Over: Update of a Systematic Review

Askar, M., Ali, K. A., Batke, M., Brugger, T., Falman, A., Robertson, A. H., Pérez, J. J., Johansen, K., de Jonge, J., Krause, T. G., et al. (2025) · Reviews in Medical Virology · doi:10.1002/rmv.70020 · Cited by 15

Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: Rationale and design of a real-world pragmatic randomized clinical trial

Hollingsworth, R. C., PALMU, A. A. I., Pépin, S., Dupuy, M., Shrestha, A., Jokinen, J., Syrjänen, R., Nealon, J., Samson, S., & Bruijn, I. D. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.03.007 · Cited by 15

Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influenza Season—A Retrospective Cohort Analysis

Levin, M. J., Divino, V. M., Shah, D., DeKoven, M., Mould-Quevedo, J. F., Pelton, S. I., & Postma, M. J. (2021) · Vaccines · doi:10.3390/vaccines9101146 · Cited by 15

SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies

Ni, B., Yanis, A., Dee, K., Chappell, J. D., Dulek, D. E., Kassim, A. A., Kitko, C. L., Thomas, L. D., & Halasa, N. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100984 · Cited by 15

Association of Post-Vaccination Adverse Reactions After Influenza Vaccine with Mortality and Cardiopulmonary Outcomes in Patients with High-Risk Cardiovascular Disease: The INVESTED Trial

Peikert, A., Claggett, B. L., Kim, K., Udell, J. A., Joseph, J., Desai, A. S., Farkouh, M. E., Hegde, S. M., Hernandez, A. F., Bhatt, D. L., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2716 · Cited by 15

Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion

Postma, M. J., Fisman, D. N., Giglio, N., Márquez-Peláez, S., Nguyen, V. H., Pugliese, A., Ruiz-Aragón, J., Urueña, A., & Mould-Quevedo, J. F. (2023) · Vaccines · doi:10.3390/vaccines11061089 · Cited by 16

Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial

Madan, A., Collins, H., Sheldon, E. A., Frenette, L., Chu, L., Friel, D., Dramé, M., Vaughn, D. W., Innis, B. L., & Schuind, A. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.013 · Cited by 15

Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults

Raviotta, J. M., Smith, K. J., DePasse, J. V., Brown, S. T., Shim, E., Nowalk, M. P., Wateska, A. R., France, G., & Zimmerman, R. K. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.069 · Cited by 15

The inflammaging microenvironment induces dysfunctional rewiring of Tfh cell differentiation

Nelson, C. S., Podestà, M. A., Gempler, M., Lee, J.-M., Batty, C. J., Mathenge, P. G., Sainju, A., Chang, M., Ke, H., Chandrakar, P., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.187271 · Cited by 14

Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients

Thomas, L. D., Batarseh, E., Hamdan, L., Haddadin, Z., Dulek, D. E., Kalams, S. A., Stewart, L. S., Stahl, A. L., Rahman, H. K., Amarin, J. Z., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad458 · Cited by 14

Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities

Moa, A., Kunasekaran, M. P., Akhtar, Z., Costantino, V., & MacIntyre, C. R. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2271304 · Cited by 17

Reduced risks of influenza-associated hospitalization and complications following vaccination among over 2 million older individuals: a nationwide study using target trial emulation framework

Peng, Z., Hua, Y., Huang, W., Wu, J., & Ou, H. (2025) · BMC Medicine · doi:10.1186/s12916-025-03955-w · Cited by 14

A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial

Johansen, N. D., Modin, D., Loiacono, M. M., Harris, R. C., Dufournet, M., Larsen, C. S., Larsen, L., Wiese, L., Dalager‐Pedersen, M., Claggett, B. L., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.07.069 · Cited by 14

Immunization in patients with inflammatory rheumatic diseases

Thomas, Κ., & Vassilopoulos, D. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.10.009 · Cited by 14

Influenza surveillance in Middle East, North, East and South Africa: Report of the 8th MENA Influenza Stakeholders Network

Abusrewil, S., Algeer, A., Aljifri, A. A., Slail, F. Y. A., Andrew, M. K., Eldin, M. A. T., Awaidy, S. T. A., Alaya, N. B. B., Khelil, J. B., Dbaibo, G. S., et al. (2019) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12628 · Cited by 14

The Immunopathobiology of SARS-CoV-2 Infection

Patel, M., Shahjin, F., Cohen, J. D., Hasan, M., Machhi, J., Chugh, H., Singh, S., Das, S., Kulkarni, T. A., Herskovitz, J., et al. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab035 · Cited by 15

Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination

Behrouzi, B., & Udell, J. A. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00973-w · Cited by 14

Estimation of Relative Vaccine Effectiveness in Influenza: A Systematic Review of Methodology

McMenamin, M. E., Bond, H. S., Sullivan, S. G., & Cowling, B. J. (2022) · Epidemiology · doi:10.1097/ede.0000000000001473 · Cited by 14

Re-randomisation trials in multi-episode settings: Estimands and independence estimators

Kahan, B. C., White, I. R., Hooper, R., & Eldridge, S. M. (2022) · Statistical Methods in Medical Research · doi:10.1177/09622802221094140 · Cited by 14

A Cohort Study on Influenza Vaccine and All-Cause Mortality in Older Adults: Methodological Concerns and Public Health Implications

Lapi, F., Marconi, E., Gualano, M. R., Vetrano, D. L., Grattagliano, I., Rossi, A., & Cricelli, C. A. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00958-7 · Cited by 14

Update on Vaccination Guidelines for Older Adults

Pilkinton, M. A., & Talbot, H. K. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13375 · Cited by 14

South African guideline for the management of community-acquired pneumonia in adults

Boyles, T. H., Brink, A. J., Calligaro, G., Cohen, C., Dheda, K. U. J., Maartens, G., Richards, G. A., & South African Thoracic Society, F. S. (2018) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v33i1.22 · Cited by 14

Canadian older adults’ perceptions of effectiveness and value of regular and high-dose influenza vaccines

Pereira, J. A., Gîlca, V., Waite, N. M., & Andrew, M. K. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1520580 · Cited by 14

Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project

Standaert, B. A., Vlaenderen, I. V., Bellinghen, L.-A. V., Talbird, S. E., Hicks, K. A., Carrico, J., & Buck, P. O. (2019) · Applied Health Economics and Health Policy · doi:10.1007/s40258-019-00534-y · Cited by 14

Introductory paper: High-dose influenza vaccine

Diaco, M., Chang, L.-J., Seet, B. T., Robertson, C., Chit, A., Mercer, M., Greenberg, D. P., Hollingsworth, R. C., & Samson, S. (2021) · Vaccine · doi:10.1016/j.vaccine.2020.09.005 · Cited by 14

Granzyme B: A Double-Edged Sword in the Response to Influenza Infection in Vaccinated Older Adults

Verschoor, C. P., Pawelec, G., Haynes, L., Loeb, M. B., Andrew, M. K., Kuchel, G. A., & McElhaney, J. E. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.753767 · Cited by 13

High-dose influenza vaccines for the prevention of hospitalization due to cardiovascular events in older adults in the nursing home: Post-hoc analysis of a cluster-randomized trial

Saade, E., Abul, Y., McConeghy, K. W., Davidson, H. E., Han, L., Joyce, N. R., Canaday, D. H., Hsueh, L., Bosco, E., & Gravenstein, S. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.09.085 · Cited by 13

Vaccination as personal public-good provision

Reddinger, J. L., Charness, G., & Levine, D. I. (2024) · Journal of Economic Behavior & Organization · doi:10.1016/j.jebo.2024.06.015 · Cited by 13

The Major Role of T Regulatory Cells in the Efficiency of Vaccination in General and Immunocompromised Populations: A Review

Stepkowski, S. M., Bekbolsynov, D., Oenick, J., Brar, S., Mierzejewska, B., Rees, M. A., & Ekwenna, O. (2024) · Vaccines · doi:10.3390/vaccines12090992 · Cited by 13

Seasonal influenza vaccination of high-risk adults

Loubet, P., Loulergue, P., Galtier, F., & Launay, O. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1188696 · Cited by 13

Association between influenza vaccination and the reduced risk of acute kidney injury among older people: A nested case-control study

Shih, C.-H., Lee, Y.-J., Chao, P.-W., Kuo, S., Ou, S., Huang, H., & Chen, Y. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.04.020 · Cited by 13

Harnessing biomaterials for therapeutic strategies against COVID-19

Colombani, T., Rogers, Z. J., Eggermont, L. J., & Bencherif, S. A. (2021) · Emergent Materials · doi:10.1007/s42247-021-00171-z · Cited by 13

Seroresponse to Inactivated and Recombinant Influenza Vaccines Among Maintenance Hemodialysis Patients

Manley, H. J., Lacson, E. K., Jr., Aweh, G. N., Li, N. C., Weiner, D. E., Miskulin, D. C., Hsu, C. M., Kapoian, T., Hayney, M. S., Meyer, K. B., et al. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.01.425 · Cited by 13

Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50–64 years of age

DiazGranados, C. A., Saway, W., Gouaux, J., Baron, M., Baker, J. P., Denis, M., Jordanov, E., Landolfi, V. A., & Yau, E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.131 · Cited by 22

Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older

Falsey, A. R., Treanor, J. J., Tornieporth, N., Capellan, J., & Gorse, G. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599790 · Cited by 388

Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015–16 to 2018–19

Balasubramani, G. K., Choi, W. S., Nowalk, M. P., Zimmerman, R. K., Monto, A. S., Martin, E. T., Belongia, E. A., McLean, H. Q., Gaglani, M., Murthy, K., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.08.011 · Cited by 23

High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009–2010 season

DiazGranados, C. A., Dunning, A. J., Jordanov, E., Landolfi, V. A., Denis, M., & Talbot, H. K. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.12.013 · Cited by 123

High-dose trivalent influenza vaccine. Efficacy and effectiveness

de Miguel, Á. G., Margüello, E. R., Díez‐Domingo, J., de Lejarazu, R. O., Martinón‐Torres, F., & Departamento de Medicina Preventiva y Salud Pública, U. R. J. C. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/043.2020 · Cited by 6